NearWave develops a compact, battery-powered device utilizing frequency domain near-infrared spectroscopy (fdNIRS) for deep tissue analysis. This technology non-invasively measures vital biomarkers like tissue oxygen saturation and hemoglobin concentrations. The scanner provides quantitative 1D and 2D mapping data for research applications in tissue oximetry and perfusion assessment.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
IFounders
Product
Problem
Current methods for monitoring tissue oxygen saturation and hemoglobin concentrations often involve invasive procedures or lack the ability to penetrate deep tissue. Existing non-invasive technologies may be bulky, slow, and difficult to use in various clinical settings. This limits the ability to obtain real-time, quantitative data for effective monitoring of tissue health.
Solution
The NearWave Scanner is a handheld device that utilizes frequency domain near-infrared spectroscopy (fdNIRS) to non-invasively measure tissue oxygen saturation and hemoglobin concentrations in deep tissue. The device provides clinicians with real-time quantitative data, displayed through an iOS companion app, to enhance monitoring capabilities. Its portability and ease of use facilitate applications ranging from clinical diagnostics to research settings. The technology offers a non-ionizing and quantitative approach to assessing vital biomarkers.
Target Audience
The primary audience includes clinicians and researchers in fields such as oncology, sports medicine, and cardiovascular health, who require quantitative assessment of tissue oxygenation and hemoglobin concentrations.
Features
- Handheld, battery-powered design for portability and ease of use
- Frequency domain near-infrared spectroscopy (fdNIRS) technology for deep tissue penetration (1-2.5cm)
- Measures tissue oxygen saturation (StO2), deoxyhemoglobin (HHb), oxyhemoglobin (HbO2), and total hemoglobin (THb) concentrations
- High-speed data acquisition (36.6kHz) for real-time 1D and 2D quantitative mapping
- iOS companion app for visual display of data
- Non-invasive and non-ionizing measurement technique